Drugs / Salvinorin A

Trials 3 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00996411 Nov 2008 → Nov 2013 Johns Hopkins University Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT03418714 Dec 2017 → Mar 2020 Johns Hopkins University Completed No outcome recorded
Phase not applicable1 trial
NCT01149824 Jun → Dec 2009 California Pacific Medical Center Research Institute Completed No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT00700596 Comparator Feb 2009 → Aug 2014 Yale University Completed No outcome recorded
Phase 11 trial
Phase 1 NCT02033707 Background Apr 2014 → Feb 2019 Johns Hopkins University Completed No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Salvinorin A “Hallucinogens: DMT, 4-phosphoryloloxy-N-diethyltryptamine, dipropyltryptamine (DPT), ketamine, dextromethorphan, mescaline, PCP, psilocybin, salvinorin-A, LSD, d-lysergic acid...” NCT02033707
4

NCT00700596

NCT00996411

NCT01149824

NCT03418714

Known as CHEMBL445332 ChEMBL registry synonym — accepted as the source's own label CHEMBL445332
Known as DIVINORIN A ChEMBL registry synonym — accepted as the source's own label CHEMBL445332
Known as SALVINORIN ChEMBL registry synonym — accepted as the source's own label CHEMBL445332
Known as SALVINORIN A (CRM) ChEMBL registry synonym — accepted as the source's own label CHEMBL445332
Modality Small molecule CHEMBL445332
Route Inhaled “An inhalation route of administration will be used” NCT03418714